| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.92T | 3.27T | 2.89T | 2.73T | 2.41T | 1.98T |
| Gross Profit | 1.04T | 1.20T | 1.03T | 964.48B | 636.22B | 299.43B |
| EBITDA | 773.85B | 908.88B | 778.32B | 748.45B | 541.16B | 249.97B |
| Net Income | 229.68B | 262.79B | 224.28B | 196.45B | 99.23B | -94.95B |
Balance Sheet | ||||||
| Total Assets | 10.10T | 10.87T | 10.17T | 9.77T | 9.41T | 9.16T |
| Cash, Cash Equivalents and Short-Term Investments | 184.76B | 263.38B | 233.67B | 281.00B | 215.19B | 171.29B |
| Total Debt | 4.63T | 5.18T | 4.65T | 4.56T | 4.46T | 4.05T |
| Total Liabilities | 7.18T | 7.79T | 7.30T | 7.03T | 6.91T | 6.74T |
| Stockholders Equity | 2.90T | 3.06T | 2.86T | 2.72T | 2.47T | 2.39T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -130.41B | -38.68B | -26.81B | 26.17B | -392.55B |
| Operating Cash Flow | 0.00 | 811.21B | 732.25B | 688.10B | 581.75B | 190.51B |
| Investing Cash Flow | 0.00 | -930.53B | -783.42B | -690.62B | -565.51B | -526.36B |
| Financing Cash Flow | 0.00 | 147.08B | 3.66B | 66.10B | 26.83B | 304.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $23.33B | 6.78 | 21.57% | 0.74% | -3.68% | 100.38% | |
72 Outperform | $163.35B | 21.15 | 40.38% | 2.32% | 1.87% | 9.41% | |
71 Outperform | $85.85B | 23.65 | 23.52% | 1.42% | -0.92% | -2.64% | |
71 Outperform | $71.89B | 29.53 | 17.43% | 1.85% | 0.60% | -19.01% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | $26.20B | 35.56 | 7.72% | 1.30% | 7.90% | 12.97% | |
54 Neutral | $18.75B | 20.61 | 10.67% | 1.73% | 4.72% | 72.71% |